Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name MEDI-573
Trade Name
Synonyms Dusigitumab
Drug Descriptions

Dusigitumab (MEDI-573) is an antibody that targets IGF-1 and IGF-2, resulting in decreased IGF-mediated signaling and potentially leading to decreased tumor growth (PMID: 25193511).

DrugClasses IGF1/2 Antibody 2
CAS Registry Number 1204390-13-5
NCIT ID C82683


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
MEDI-573 MEDI-573 0 0
MEDI-573 + Sirolimus MEDI-573 Sirolimus 0 0
MEDI-573 + Vistusertib MEDI-573 Vistusertib 0 0

Additional content available in CKB BOOST